<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Rescriptor</title><link>http://www.unboundmedicine.com/medline/ebm/research/Rescriptor</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18473749/full_citation/Drugs_Behave_as_Substrates_Inhibitors_and_Inducers_of_Human_Cytochrome_P450_3A4_</link><description>Zhou SF <br/><span class="title">Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4. [Journal Article]</span><br/><span class="source" title="Current drug metabolism">Curr Drug Metab 2008 May; 9(4):310-2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18473749/abstract/Drugs_Behave_as_Substrates_Inhibitors_and_Inducers_of_Human_Cytochrome_P450_3A4_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18473749/full_citation/Drugs_Behave_as_Substrates_Inhibitors_and_Inducers_of_Human_Cytochrome_P450_3A4_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18473749/Drugs_Behave_as_Substrates_Inhibitors_and_Inducers_of_Human_Cytochrome_P450_3A4_">Find Related Articles</a> </description></item><item><title>A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18462814/full_citation/A_study_of_seven_rule_based_algorithms_for_the_interpretation_of_HIV_1_genotypic_resistance_data_in_Thailand_</link><description>Poonpiriya V, Sungkanuparph S, Leechanachai P, et al. <br/><span class="title">A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of virological methods">J Virol Methods 2008 May 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18462814/abstract/A_study_of_seven_rule_based_algorithms_for_the_interpretation_of_HIV_1_genotypic_resistance_data_in_Thailand_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18462814/full_citation/A_study_of_seven_rule_based_algorithms_for_the_interpretation_of_HIV_1_genotypic_resistance_data_in_Thailand_">Full Citation</a></description></item><item><title>Quantification of the HIV-integrase inhibitor raltegravir (MK-0518) in human plasma by high-performance liquid chromatography with fluorescence detection.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18434263/full_citation/Quantification_of_the_HIV_integrase_inhibitor_raltegravir__MK_0518__in_human_plasma_by_high_performance_liquid_chromatography_with_fluorescence_detection_</link><description>Poirier JM, Robidou P, Jaillon P <br/><span class="title">Quantification of the HIV-integrase inhibitor raltegravir (MK-0518) in human plasma by high-performance liquid chromatography with fluorescence detection. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of chromatography. B, Analytical technologies in the biomedical and life sciences">J Chromatogr B Analyt Technol Biomed Life Sci 2008 Apr 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18434263/abstract/Quantification_of_the_HIV_integrase_inhibitor_raltegravir__MK_0518__in_human_plasma_by_high_performance_liquid_chromatography_with_fluorescence_detection_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18434263/full_citation/Quantification_of_the_HIV_integrase_inhibitor_raltegravir__MK_0518__in_human_plasma_by_high_performance_liquid_chromatography_with_fluorescence_detection_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18434263/Quantification_of_the_HIV_integrase_inhibitor_raltegravir__MK_0518__in_human_plasma_by_high_performance_liquid_chromatography_with_fluorescence_detection_">Find Related Articles</a> </description></item><item><title>[HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy]</title><link>http://www.unboundmedicine.com/medline/ebm/record/18396628/full_citation/[HIV_1_genotypic_resistance_profiles_in_children_failing_highly_active_antiretroviral_therapy]</link><description>Liu ZY, Wei HS, Zhao HX, et al. <br/><span class="title">[HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy] [English Abstract, Journal Article]</span><br/><span class="source" title="Zhonghua yi xue za zhi">Zhonghua Yi Xue Za Zhi 2007 Dec 11; 87(46):3292-4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18396628/abstract/[HIV_1_genotypic_resistance_profiles_in_children_failing_highly_active_antiretroviral_therapy]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18396628/full_citation/[HIV_1_genotypic_resistance_profiles_in_children_failing_highly_active_antiretroviral_therapy]">Full Citation</a></description></item><item><title>Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: Introducing a diketoacid functionality into delavirdine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18314335/full_citation/Design_and_synthesis_of_dual_inhibitors_of_HIV_reverse_transcriptase_and_integrase:_Introducing_a_diketoacid_functionality_into_delavirdine_</link><description>Wang Z, Vince R <br/><span class="title">Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: Introducing a diketoacid functionality into delavirdine. [JOURNAL ARTICLE]</span><br/><span class="source" title="Bioorganic &amp; medicinal chemistry">Bioorg Med Chem 2008 Feb 8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18314335/abstract/Design_and_synthesis_of_dual_inhibitors_of_HIV_reverse_transcriptase_and_integrase:_Introducing_a_diketoacid_functionality_into_delavirdine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18314335/full_citation/Design_and_synthesis_of_dual_inhibitors_of_HIV_reverse_transcriptase_and_integrase:_Introducing_a_diketoacid_functionality_into_delavirdine_">Full Citation</a></description></item><item><title>Amino Acid Mutation N348I in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Multi-class Resistance to Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitors.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18216099/full_citation/Amino_Acid_Mutation_N348I_in_the_Connection_Subdomain_of_HIV_1_Reverse_Transcriptase_Confers_Multi_class_Resistance_to_Nucleoside_and_Non_nucleoside_Reverse_Transcriptase_Inhibitors_</link><description>Hachiya A, Kodama EN, Sarafianos SG, et al. <br/><span class="title">Amino Acid Mutation N348I in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Multi-class Resistance to Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitors. [JOURNAL ARTICLE]</span><br/><span class="source" title="">J Virol 2008 Jan 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18216099/abstract/Amino_Acid_Mutation_N348I_in_the_Connection_Subdomain_of_HIV_1_Reverse_Transcriptase_Confers_Multi_class_Resistance_to_Nucleoside_and_Non_nucleoside_Reverse_Transcriptase_Inhibitors_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18216099/full_citation/Amino_Acid_Mutation_N348I_in_the_Connection_Subdomain_of_HIV_1_Reverse_Transcriptase_Confers_Multi_class_Resistance_to_Nucleoside_and_Non_nucleoside_Reverse_Transcriptase_Inhibitors_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18216099/Amino_Acid_Mutation_N348I_in_the_Connection_Subdomain_of_HIV_1_Reverse_Transcriptase_Confers_Multi_class_Resistance_to_Nucleoside_and_Non_nucleoside_Reverse_Transcriptase_Inhibitors_">Find Related Articles</a> </description></item><item><title>Addressing Ceiling Effects in Health Status Measures: A Comparison of Techniques Applied to Measures for People with HIV Disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18211533/full_citation/Addressing_Ceiling_Effects_in_Health_Status_Measures:_A_Comparison_of_Techniques_Applied_to_Measures_for_People_with_HIV_Disease_</link><description>Huang IC, Frangakis C, Atkinson MJ, et al. <br/><span class="title">Addressing Ceiling Effects in Health Status Measures: A Comparison of Techniques Applied to Measures for People with HIV Disease. [Journal Article]</span><br/><span class="source" title="Health services research">Health Serv Res 2008 Feb; 43(1 Pt 1):327-39.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18211533/abstract/Addressing_Ceiling_Effects_in_Health_Status_Measures:_A_Comparison_of_Techniques_Applied_to_Measures_for_People_with_HIV_Disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18211533/full_citation/Addressing_Ceiling_Effects_in_Health_Status_Measures:_A_Comparison_of_Techniques_Applied_to_Measures_for_People_with_HIV_Disease_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18211533/Addressing_Ceiling_Effects_in_Health_Status_Measures:_A_Comparison_of_Techniques_Applied_to_Measures_for_People_with_HIV_Disease_">Find Related Articles</a> </description></item><item><title>Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18172393/full_citation/Characterization_of_HIV_1_subtypes_and_viral_antiretroviral_drug_resistance_in_men_who_have_sex_with_men_in_Beijing_China_</link><description>Zhang X, Li S, Li X, et al. <br/><span class="title">Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="AIDS (London, England)">AIDS 2007 Dec.:S59-65.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18172393/abstract/Characterization_of_HIV_1_subtypes_and_viral_antiretroviral_drug_resistance_in_men_who_have_sex_with_men_in_Beijing_China_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18172393/full_citation/Characterization_of_HIV_1_subtypes_and_viral_antiretroviral_drug_resistance_in_men_who_have_sex_with_men_in_Beijing_China_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fan=00002030-200712008-00010">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18172393/Characterization_of_HIV_1_subtypes_and_viral_antiretroviral_drug_resistance_in_men_who_have_sex_with_men_in_Beijing_China_">Find Related Articles</a> </description></item><item><title>Nelfinavir and non-nucleoside reverse transcriptase inhibitor-based salvage regimens in heavily HIV pretreated patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18159457/full_citation/Nelfinavir_and_non_nucleoside_reverse_transcriptase_inhibitor_based_salvage_regimens_in_heavily_HIV_pretreated_patients_</link><description>Baril JG, Lefebvre EA, Lalonde RG, et al. <br/><span class="title">Nelfinavir and non-nucleoside reverse transcriptase inhibitor-based salvage regimens in heavily HIV pretreated patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Can J Infect Dis 2003 7; 14(4):201-205.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18159457/abstract/Nelfinavir_and_non_nucleoside_reverse_transcriptase_inhibitor_based_salvage_regimens_in_heavily_HIV_pretreated_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18159457/full_citation/Nelfinavir_and_non_nucleoside_reverse_transcriptase_inhibitor_based_salvage_regimens_in_heavily_HIV_pretreated_patients_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18159457/Nelfinavir_and_non_nucleoside_reverse_transcriptase_inhibitor_based_salvage_regimens_in_heavily_HIV_pretreated_patients_">Find Related Articles</a> </description></item><item><title>Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18043468/full_citation/Clinically_Important_Drug_Interactions_Potentially_Involving_Mechanism_based_Inhibition_of_Cytochrome_P450_3A4_and_the_Role_of_Therapeutic_Drug_Monitoring_</link><description>Zhou SF, Xue CC, Yu XQ, et al. <br/><span class="title">Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Ther Drug Monit 2007 Dec; 29(6):687-710.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18043468/abstract/Clinically_Important_Drug_Interactions_Potentially_Involving_Mechanism_based_Inhibition_of_Cytochrome_P450_3A4_and_the_Role_of_Therapeutic_Drug_Monitoring_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18043468/full_citation/Clinically_Important_Drug_Interactions_Potentially_Involving_Mechanism_based_Inhibition_of_Cytochrome_P450_3A4_and_the_Role_of_Therapeutic_Drug_Monitoring_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18043468/Clinically_Important_Drug_Interactions_Potentially_Involving_Mechanism_based_Inhibition_of_Cytochrome_P450_3A4_and_the_Role_of_Therapeutic_Drug_Monitoring_">Find Related Articles</a> </description></item></channel></rss>